Related references
Note: Only part of the references are listed.Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
Ffolliott M. Fisher et al.
GASTROENTEROLOGY (2014)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
Dissociating fatty liver and diabetes
Zheng Sun et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Timothy V. Beischlag et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Zheng Sun et al.
NATURE MEDICINE (2012)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis
Hong Lu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Fibroblast growth factor 21: from pharmacology to physiology
Steven A. Kliewer et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Jung Hoon Lee et al.
GASTROENTEROLOGY (2010)
Diacylglycerol-mediated insulin resistance
Derek M. Erion et al.
NATURE MEDICINE (2010)
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway
Mary D. L. Chau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Anthony E. Boitano et al.
SCIENCE (2010)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang et al.
CELL METABOLISM (2009)
The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity
Jie Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The search for endogenous activators of the aryl hydrocarbon receptor
Linh P. Nguyen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Causes and Metabolic Consequences of Fatty Liver
Norbert Stefan et al.
ENDOCRINE REVIEWS (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
Mara Monetti et al.
CELL METABOLISM (2007)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake et al.
NATURE (2007)
Review: The role of insulin resistance in nonalcoholic fatty liver disease
Kristina M. Utzschneider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway
Jie Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1
WJ Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice
AC Heijboer et al.
JOURNAL OF LIPID RESEARCH (2005)
IKK-β links inflammation to obesity-induced insulin resistance
MC Arkan et al.
NATURE MEDICINE (2005)
Metformin in the treatment of patients with non-alcoholic steatohepatitis
A Uygun et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Linking dioxins to diabetes: Epidemiology and biologic plausibility
RBJ Remillard et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2002)
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
N Maeda et al.
NATURE MEDICINE (2002)
Definition of a dioxin receptor mutant that is a constitutive activator of transcription - Delineation of overlapping repression and ligand binding functions within the PAS domain
J McGuire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)